Silent thyroiditis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Overview
Silent thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain’s thyroiditis, Hashimoto’s thyroiditis, Riedel’s thyroiditis, and suppurative thyroiditis. Silent thyroiditis must also be differentiated from other diseases which cause hypothyroidism. As silent thyroiditis may cause transient thyrotoxic symptoms, the diseases causing thyrotoxicosis must also be considered in the differential diagnosis.
Differentiating Silent Thyroiditis from other Diseases
Differentiating Silent Thyroiditis from other Diseases
Differentiating silent thyroiditis from other causes of thyroiditis
- Silent thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain’s thyroiditis, Hashimoto’s thyroiditis, Riedel’s thyroiditis, and suppurative thyroiditis.[1]
| Conditions | Causes | Age at onset | Pathological findings | Diagnostic approach |
|---|---|---|---|---|
| Silent thyroiditis |
|
|
| |
| Hashimoto’s thyroiditis |
|
|
| |
| Painful subacute (De Quervain’s) thyroiditis |
|
|
|
|
| Postpartum thyroiditis |
|
|
| |
| Riedel’s thyroiditis |
|
|
|
|
| Suppurative thyroiditis |
|
|
|
Differentiating silent thyroiditis from other causes of hypothyroidism
- Silent thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[2][3][1][4][5][6]
| Disease | History and symptoms | Laboratory findings | Additional findings | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fever | Pain | TSH | Free T4 | T3 | T3RUβ | Thyroglobin | TRH | TPOAb^ | |||
| Transient hypothyroidism | Silent thyroiditis | – | – | β/β | β/β | Normal | β | β | Normal | Present (high titer) |
|
| Postpartum thyroiditis | +/- | +/- | β/β | β/β | Normal | β | β | Normal/β | Present (high titer) |
| |
| Subacute (de Quervain’s) thyroiditis | +/- | +/- | β/β | β/β | Normal | β | β | Normal | Low/absent |
| |
| Primary hypothyroidism | Autoimmune (Hashimoto’s thyroiditis) | – | – | β* | β | Normal/β | Normal/β | Normal/β | Normal | Present (high titer) |
|
| Riedel’s thyroiditis | – | – | Normal/β | Normal/β | Normal/β | Normal/β | Normal | Normal | Usually present |
| |
| Infectious thyroiditis | + | + | Normal | Normal | Normal | Normal | Normal | Normal | Absent |
| |
| Others | Drug-induced | – | – | β/β | β/β | Normal | β | Normal/β | Normal | Absent** |
|
| Radiation-induced | |||||||||||
| Trauma induced | |||||||||||
| Radioiodine induced | |||||||||||
| Thyroidectomy | |||||||||||
| Subclinical hypothyroidism | – | – | β | Normal | Normal | Normal | Normal | Normal | Normal/β |
| |
Differentiating silent thyroiditis from other causes of thyrotoxicosis
- Silent thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.[2][3][1][4][5][6][7][8][9]
| Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fever | Pain | TSH | Free T4 | T3 | T3RUβ | Thyroglobin | TRH | TSH Receptor Antibody | TPOAb^ | |||
| Thyroiditis | Silent thyroiditis | – | – | β/β | β/β | Normal | β | β | Normal | Absent | Present (high titer) |
|
| Hashimoto’s thyroiditis (Hashitoxicosis) | – | – | β* | β | Normal/β | Normal/β | Normal/β | Normal | Absent | Present (high titer) |
| |
| Subacute (de Quervain’s) thyroiditis | +/- | +/- | β/β | β/β | Normal | β | β | Normal | Absent | Low/absent |
| |
| Postpartum thyroiditis | +/- | +/- | β/β | β/β | Normal | β | β | Normal/β | Absent | Present (high titer) |
| |
| Primary hyperthyroidism | Grave’s disease | – | – | β | β | Normal/β | β | β | Normal | Present | Absent |
|
| Toxic thyroid nodule | – | – | β | β | Normal/β | β(hot nodule) | Normal/β | Normal | Absent | Absent |
– | |
| Secondary hyperthyroidism | Pituitary adenoma | – | – | β | β | Normal/β | β | Normal/β | Normal | Absent | Absent |
|
| Tertiary hyperthyroidism | Tertiary hyperthyroidism | – | – | β | β | β | β | Normal/β | β | Absent | Absent |
|
| Drug induced | Amiodarone type 1 | – | – | β | β | Normal/β | β | Normal/β | Normal | Absent | Absent |
|
| Amiodarone type 2 | – | – | β | β | Normal/β | Absent/β | Normal/β | Normal | Absent | Absent |
| |
| Others | Factitious thyrotoxicosis | – | – | β | β | Normal/β | β | β | Normal | Absent | Absent |
|
| Trophoblastic disease | – | – | β | β | Normal/β | β | – | Normal | Absent | Absent |
– | |
| Struma ovarii | – | – | β | β | Normal/β | β | – | Normal | Absent | Absent |
– | |
(β )T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies.
References
References
- β 1.0 1.1 1.2 “Thyroiditis β NEJM”.
- β 2.0 2.1 Bindra A, Braunstein GD (2006). “Thyroiditis”. Am Fam Physician. 73 (10): 1769β76. PMIDΒ 16734054.
- β 3.0 3.1 McDermott MT (2009). “In the clinic. Hypothyroidism”. Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMIDΒ 19949140.
- β 4.0 4.1 Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). “Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)”. Thyroid. 17 (12): 1211β23. doi:10.1089/thy.2006.0235. PMIDΒ 18177256.
- β 5.0 5.1 Lania A, Persani L, Beck-Peccoz P (2008). “Central hypothyroidism”. Pituitary. 11 (2): 181β6. doi:10.1007/s11102-008-0122-6. PMIDΒ 18415684.
- β 6.0 6.1 De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. “Clinical Strategies in the Testing of Thyroid Function”. PMIDΒ 25905413.
- β “Clinical Finding and Thyroid Function in Women with Struma Ovarii”.
- β Vaidya B, Pearce SH (2014). “Diagnosis and management of thyrotoxicosis”. BMJ. 349: g5128. PMIDΒ 25146390.
- β “Think thyrotoxicosis factitia – measure thyroglobulin | The BMJ”.
β
Looking for the patient version?
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
